Life must keep moving. Innova Medical Group's testing solutions will meet your unique transportation needs.
In our interconnected world, transportation remains one of the most vital services both for economic activity and freedom of movement. Responding to the COVID-19 pandemic across the globe, more countries have shut down borders and limited travel. Through testing, monitoring, and implementation, Innova Medical Group pledges to build a sense of security for travelers whether by trains, planes, cruise ships, trucks, or public transportation. Frequent, convenient, and affordable testing can give travelers a sense of security and let them make an informed choice. Most importantly, protecting essential workers, in each of these industries, can minimize risk to public health.
In addition to providing test kits, Innova Medical Group partners with customers to build testing protocols that fit unique requirements and provides a Fast Healthcare Interoperability Resources (FHIR) compliant digital solution for communicating COVID-19 testing results. Besides healthcare personnel, through Ashfield, an Artificial Intelligence (AI) powered chatbot can answer questions about testing, 24/7.
Mass testing should be available at transportation hubs to identify people who are infectious, asymptomatic, and pre-symptomatic. The INNOVA SARS-CoV-2 Antigen Rapid Qualitative Test can safely reopen rail travel and save thousands of jobs. The pandemic has plunged ridership and created billions of dollars in losses. Estimates show that up to 90 percent of train employees already have been furloughed.
Saving rail transport, both high-speed rail and freight traffic, is essential for smooth global shipping and building a greener future with ecologically-sound train travel.